TSA-II – NeuroSensory Analyzer

NeuroSensory Analyzer

An essential Quantitative Sensory Testing (QST) tool for evaluating nerve impairment and sensory testing in clinical, research and pharmacological trial settings

What is TSA-II? 

TSA-II – NeuroSensory Analyzer is a precise, computer-controlled device capable of generating and documenting response to highly repeatable thermal and vibratory stimuli, such as warmth, cold, heat-induced pain, cold-induced pain or vibration.


What would the results show? 

A deviation from the normal range can indicate the existence of peripheral nerve disease or damage due to injury, illness or toxic exposure. Testing comparing contra-lateral body sites and longitudinal (or serial) evaluation before and after therapy can also be routinely employed.

TSA-II Features

  • Outcome-based color graphic reports with automated narrative discussion of test results for insurance and referral networks
  • Automatic comparison of test results to normative reference data
  • Portable, fast set-up and ease of use
  • Versatile WINDOWST based software with selection of test paradigms for maximum flexibility in clinical, research and drug trial applications.
  • Various test methods (Limits, Levels and Manual)
  • Factory installed default protocols for immediate clinical use
  • Proven Repeatability

Useful in monitoring, treating and testing in:

  • Fibromyalgia
  • Painful neuropathies
  • Lumbar Radiculopathy
  • Small-fiber allodynia in Complex Regional Pain Syndrome (CRPS)
  • Underlying Central Nervous System impairment in difficult-to-diagnose patients
  • Early detection of diabetic neuropathy of small-caliber nerve fibers
  • Effectiveness of growth factors, aldosereductase
  • Inhibitors and other new therapies
  • Entrapment and toxic neuropathies
  • Testing programs to detect malingerers
  • Nerve root compression and inflammation

TSA brochure

Q-Sense FMRI Brochure